Program in Chemical Biology, University of Michigan, Ann Arbor, Michigan.
Department of Pharmaceutical Chemistry, University of California San Francisco, San Francisco, California.
Mol Cancer Res. 2018 Jan;16(1):58-68. doi: 10.1158/1541-7786.MCR-17-0408. Epub 2017 Sep 28.
Hsp70 is a molecular chaperone that binds to "client" proteins and protects them from protein degradation. Hsp70 is essential for the survival of many cancer cells, but it is not yet clear which of its clients are involved. Using structurally distinct chemical inhibitors, we found that many of the well-known clients of the related chaperone, Hsp90, are not strikingly responsive to Hsp70 inhibition. Rather, Hsp70 appeared to be important for the stability of the RIP1 (RIPK1) regulators: cIAP1/2 (BIRC1 and BIRC3), XIAP, and cFLIP (CFLAR). These results suggest that Hsp70 limits apoptosis and necroptosis pathways downstream of RIP1. Consistent with this model, MDA-MB-231 breast cancer cells treated with Hsp70 inhibitors underwent apoptosis, while cotreatment with z-VAD.fmk switched the cell death pathway to necroptosis. In addition, cell death in response to Hsp70 inhibitors was strongly suppressed by RIP1 knockdown or inhibitors. Thus, these data indicate that Hsp70 plays a previously unrecognized and important role in suppressing RIP1 activity. These findings clarify the role of Hsp70 in prosurvival signaling and suggest IAPs as potential new biomarkers for Hsp70 inhibition. .
热休克蛋白 70(Hsp70)是一种分子伴侣,它与“客户”蛋白结合并保护它们免受蛋白质降解。Hsp70 对于许多癌细胞的存活至关重要,但目前尚不清楚其客户蛋白中有哪些参与其中。我们使用结构不同的化学抑制剂发现,许多与相关伴侣 Hsp90 相关的众所周知的客户蛋白对 Hsp70 抑制的反应并不明显。相反,Hsp70 似乎对 RIP1(RIPK1)调节剂的稳定性很重要:cIAP1/2(BIRC1 和 BIRC3)、XIAP 和 cFLIP(CFLAR)。这些结果表明 Hsp70 限制了 RIP1 下游的细胞凋亡和坏死性细胞死亡途径。与该模型一致,用 Hsp70 抑制剂处理 MDA-MB-231 乳腺癌细胞后会发生细胞凋亡,而用 z-VAD.fmk 共同处理则会将细胞死亡途径切换为坏死性细胞死亡。此外,RIP1 敲低或抑制剂强烈抑制了对 Hsp70 抑制剂的细胞死亡。因此,这些数据表明 Hsp70 在抑制 RIP1 活性方面发挥了以前未被认识到的重要作用。这些发现阐明了 Hsp70 在生存信号中的作用,并表明 IAP 作为 Hsp70 抑制的潜在新生物标志物。